EMulate Therapeutics, Inc. (EMTX)
EMulate Therapeutics was planning to go public, but the IPO was withdrawn on Jul 31, 2024.
IPO Price Range
$4.00 - $6.00
Shares Offered
2,300,000
Deal Size
$11.50M
EMulate Therapeutics Revenue
EMulate Therapeutics had revenue of $255.00K in the twelve months ending June 30, 2022. In the year 2021, EMulate Therapeutics had annual revenue of $241.00K with 113.27% growth.
Revenue (ttm)
$255.00K
Revenue Growth
+113.27%
P/S Ratio
271.81
Revenue / Employee
$36,429
Employees
7
Market Cap
69.31M
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2021 | 241.00K | 128.00K | 113.27% |
| Dec 31, 2020 | 113.00K | - | - |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionEMTX News
- 3 years ago - Medical device developer EMulate Therapeutics files for a $15 million IPO - Renaissance Capital
- 3 years ago - EMulate Therapeutics IPO Registration Document (S-1) - SEC